RDUS stock touches 52-week high at $29.6 amid market optimism

Radius Health (RDUS) stock reached a 52-week high, up nearly 98% year-to-date, though InvestingPro analysis suggests it's trading above fair value amid concerns about debt and profit margins. Separately, Radius Recycling, Inc. announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its proposed $1.34 billion merger with Toyota Tsusho America, expected to close in the latter half of 2025 at $30 per share, pending shareholder and regulatory approvals.

Analysis

Radius Recycling, Inc. (RDUS) stock achieved a 52-week high of $29.64, reflecting a year-to-date gain of 97.7%, primarily influenced by its pending acquisition by a subsidiary of Toyota Tsusho America, Inc. (TM). A significant milestone was reached with the announced early termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period for the merger, effective May 12, 2025. This merger, valued at approximately $1.34 billion, proposes an acquisition price of $30.00 per share in cash for all outstanding Radius Recycling shares. The transaction is expected to conclude in the latter half of 2025, contingent upon shareholder approval and other regulatory clearances. While InvestingPro analysis noted the stock of Radius Health (RDUS_OLD, potentially a related or former entity) as trading above fair value with underlying financial weaknesses such as significant debt and weak profit margins, the current market valuation of RDUS near the $30.00 offer signifies that the merger terms are the dominant pricing factor. Upon completion, the deal is anticipated to bolster Radius Recycling’s financial standing and expand its business avenues.

Key Decisions for Investors

• For current RDUS shareholders, the primary consideration is the realization of value at or near the $30.00 per share cash offer, dependent on the successful closure of the acquisition by Toyota Tsusho America.
• Potential new investors should note the limited upside from the current price of $29.64 to the $30.00 offer, with returns representing a small arbitrage spread that is subject to the risk of the deal not completing.
• Close monitoring of pending conditions, such as shareholder votes and final regulatory approvals, is crucial, as failure to satisfy these could lead to the termination of the merger and a subsequent re-evaluation of RDUS's share price.